Teva Pharmaceutical Industries (TEVA) Asset Utilization Ratio (2018 - 2026)

Teva Pharmaceutical Industries has disclosed Asset Utilization Ratio across 9 years of filings, most recently posting 0.43 for Q1 2026.

• Quarterly Asset Utilization Ratio rose 9.21% year-over-year to 0.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.43 (up 9.21% YoY) and the FY2025 annual result came in at 0.43, up 7.87% from the prior year.
• Asset Utilization Ratio held at 0.43 in Q1 2026, from 0.43 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.43 in Q1 2026 and troughed at 0.33 in Q1 2022.
• A 5-year average of 0.37 and a median of 0.37 in 2024 frame the typical range for Asset Utilization Ratio.
• Biggest YoY gain for Asset Utilization Ratio was 14.1% in 2025; the steepest drop was 4.32% in 2025.
• Tracing TEVA's Asset Utilization Ratio over 5 years: stood at 0.34 in 2022, then grew by 9.5% to 0.37 in 2023, then increased by 1.33% to 0.38 in 2024, then increased by 14.1% to 0.43 in 2025, then increased by 0.3% to 0.43 in 2026.
• Business Quant data shows TEVA's Asset Utilization Ratio at 0.43 in Q1 2026, 0.43 in Q4 2025, and 0.39 in Q3 2025.